NASDAQ:YJYunji Stock Price, Forecast & News

Yunji's stock was trading at $3.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, YJ stock has decreased by 26.8% and is now trading at $2.82. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Yunji in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Yunji.

Yunji is scheduled to release its next quarterly earnings announcement on Thursday, August 27th 2020. View our earnings forecast for Yunji.

Yunji Inc (NASDAQ:YJ) released its quarterly earnings data on Wednesday, June, 3rd. The company reported $0.12 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.07. The business earned $232.91 million during the quarter. Yunji had a negative net margin of 1.55% and a negative return on equity of 7.60%. View Yunji's earnings history.

News stories about YJ stock have trended negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Yunji earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Yunji.

Some companies that are related to Yunji include Sally Beauty (SBH), 1-800-Flowers.Com (FLWS), Star Group (SGU), Titan Machinery (TITN), Secoo (SECO), Kirkland's (KIRK) and SpendSmart Networks (SSPC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Yunji investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Wells Fargo & Co (WFC), CBTX (CBTX), Energy Transfer LP Unit (ET), Gilead Sciences (GILD), General Motors (GM), GlaxoSmithKline (GSK), IBM (IBM) and Kohl's (KSS).

(YJ) raised $155 million in an IPO on Friday, May 3rd 2019. The company issued 13,500,000 shares at $11.00-$12.00 per share. Morgan Stanley, Credit Suisse, J.P. Morgan and CICC acted as the underwriters for the IPO.

Yunji trades on the NASDAQ under the ticker symbol "YJ."

Shares of YJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of YJ stock can currently be purchased for approximately $2.82.

Yunji has a market capitalization of $608.16 million and generates $1.68 billion in revenue each year. The company earns $-18,070,000.00 in net income (profit) each year or ($1.31) on an earnings per share basis. Yunji employs 1,334 workers across the globe.

The official website for Yunji is www.yunjiglobal.com.

Yunji's mailing address is 15/F SOUTH BUILDING HIPARK PHASE 2 XIAOSHAN DISTRICT, HANGZHOU F4, 310000. The company can be reached via phone at 86-571-8168-8920 or via email at [email protected]